The novel treatment of this peptide represents a significant breakthrough in the handling of type 2 diabetes. Unlike existing therapies, tirzepatide affects dual pathways – GLP-1 and glucose-dependent insulinotropic https://tirzepatidepeptide625643.newbigblog.com/48994209/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment